Word: lungingly
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...watch out. Those supposedly apocryphal tales of spouses who die within days of each other have more than a little truth to them. A 2007 British study found that at any given moment, a bereaved spouse has a greater risk of death from just about any cause (except, oddly, lung cancer) than a still married person. "Over time," says Coan, "your brain becomes used to the other person as part of your emotional-regulation strategy. You take that person away, and you become what we dryly call dysregulated--weepy, mournful, stay up half the night. This can come from death...
...hometowns, even opening taxi doors. Once, after Salvador Dalí had dined with his cat, the tactful and kind Vrinat offered, "Perhaps next time it would be best if your friend didn't come. I had the sense he didn't particularly enjoy himself." Vrinat was 71 and had lung cancer...
...time, it looked as if Stephen King would never reach retirement age. Nine years ago, a pickup truck slammed into him on the side of a Maine road. One of his legs shattered, a lung collapsed, several ribs broke and his hip fractured. A few years later, after developing a severe case of pneumonia, the king of chills decided to embrace warmth. "It's the law," he jokes from his part-time home on the Gulf Coast. "You get a little bit older, and you have to move to Florida." So, in one of the rare cliché moments...
...approved anticancer drugs that weaken tumors by blocking their blood supply. "The idea was met with skepticism and ridicule back then, but he doggedly persisted in proving his ideas," says Li. "He lived long enough to see his idea transformed into new treatments for colon cancer, lung cancer, kidney cancer, liver cancer and multiple myeloma...
...Folkman's first compound, which biotech companies rushed to test in people at the beginning of this decade, proved less effective in patients than in mice, giving skeptics yet another reason to doubt the approach. But that agent, dismissed by U.S. researchers, eventually won approval in 2005 for treating lung cancer in China, where it is extending the lives of non-small-cell lung cancer patients...